1976
DOI: 10.1073/pnas.73.6.2043
|View full text |Cite
|
Sign up to set email alerts
|

A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug.

Abstract: Purified rat liver peroxisomes contain a cyanide-insensitive fatty acyl-CoA oxidizing system that uses 02 and NAD as electron acceptors. The system was detected by the ability of added palmitoylCoA to elicit 02 consumption, H202 production, and Ordependent NAD reduction. The activity of this system is increased approximately one order of magnitude in rats treated with clofibrate, a hypolipidemic drug known to cause peroxisomal proliferation. The possibility that rat liver peroxisomes may be involved in lipid m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

16
384
3
3

Year Published

1978
1978
2011
2011

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 950 publications
(406 citation statements)
references
References 22 publications
16
384
3
3
Order By: Relevance
“…In contrast with this view, Reddy et al (25) reported recently that when clofibrate was administrated to rats with allylisopropylacetamide, which is a inhibitor of catalase synthesis, the increase in the number of microbodies still occurred even though the increase in hepatic catalase activity was negligible, while serum cholesterol and triglyceride were lowered. In fact, Lazarow et al (12) and Goldenberg et al (6), suggested that the peroxisomal fatty acyl-CoA oxidizing system and carnitin acetyltransferase might play more important roles in hypolipidemic action and give the best explanation for a close connection between hypolipidemic effect and microbody proliferation. These results indicate that catalase in hepatic microbodies is not essential for affecting the lipid metabolism, and its increase reflects only the increase in the number of microbodies, as was also pointed out by Goldenberg et al (6).…”
Section: Discussionmentioning
confidence: 99%
“…In contrast with this view, Reddy et al (25) reported recently that when clofibrate was administrated to rats with allylisopropylacetamide, which is a inhibitor of catalase synthesis, the increase in the number of microbodies still occurred even though the increase in hepatic catalase activity was negligible, while serum cholesterol and triglyceride were lowered. In fact, Lazarow et al (12) and Goldenberg et al (6), suggested that the peroxisomal fatty acyl-CoA oxidizing system and carnitin acetyltransferase might play more important roles in hypolipidemic action and give the best explanation for a close connection between hypolipidemic effect and microbody proliferation. These results indicate that catalase in hepatic microbodies is not essential for affecting the lipid metabolism, and its increase reflects only the increase in the number of microbodies, as was also pointed out by Goldenberg et al (6).…”
Section: Discussionmentioning
confidence: 99%
“…Subcellular marker enzymes were assayed according to the following methods: succinate dehydrogenase (King, 1967) for mitochondria; palmitoyl-CoA oxidase (Lazarow and De Duve, 1976) for peroxisomes; NADPH-cytochrome c reductase (Beaufay et al, 1974) for microsomes and glyceraldehyde 3-phosphate dehydrogenase (Serrano et al, 1991) for cytosol.…”
Section: Enzyme Assaysmentioning
confidence: 99%
“…Catalase activity in the peroxisomal fraction was measured by the method of Aebi (1974). The activity of peroxisomal cyanide-insensitive fl-oxidation of fatty acids was determined by recording the reduction of NAD to NADH spectrophotometrically in the reaction of the /3-oxidation spiral (Lazarow and de Duve 1976).…”
Section: Methodsmentioning
confidence: 99%